HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced activity of meprin-α, a pro-migratory and pro-angiogenic protease, in colorectal cancer.

Abstract
Meprin-α is a metalloprotease overexpressed in cancer cells, leading to the accumulation of this protease in a subset of colorectal tumors. The impact of increased meprin-α levels on tumor progression is not known. We investigated the effect of this protease on cell migration and angiogenesis in vitro and studied the expression of meprinmRNA, protein and proteolytic activity in primary tumors at progressive stages and in liver metastases of patients with colorectal cancer, as well as inhibitory activity towards meprin-α in sera of cancer patient as compared to healthy controls. We found that the hepatocyte growth factor (HGF)-induced migratory response of meprin-transfected epithelial cells was increased compared to wild-type cells in the presence of plasminogen, and that the angiogenic response in organ-cultured rat aortic explants was enhanced in the presence of exogenous human meprin-α. In patients, meprinmRNA was expressed in colonic adenomas, primary tumors UICC (International Union Against Cancer) stage I, II, III and IV, as well as in liver metastases. In contrast, the corresponding protein accumulated only in primary tumors and liver metastases, but not in adenomas. However, liver metastases lacked meprin-α activity despite increased expression of the corresponding protein, which correlated with inefficient zymogen activation. Sera from cancer patients exhibited reduced meprin-α inhibition compared to healthy controls. In conclusion, meprin-α activity is regulated differently in primary tumors and metastases, leading to high proteolytic activity in primary tumors and low activity in liver metastases. By virtue of its pro-migratory and pro-angiogenic activity, meprin-α may promote tumor progression in colorectal cancer.
AuthorsDaniel Lottaz, Christoph A Maurer, Agnès Noël, Silvia Blacher, Maya Huguenin, Alexandra Nievergelt, Verena Niggli, Alexander Kern, Stefan Müller, Frank Seibold, Helmut Friess, Christoph Becker-Pauly, Walter Stöcker, Erwin E Sterchi
JournalPloS one (PLoS One) Vol. 6 Issue 11 Pg. e26450 ( 2011) ISSN: 1932-6203 [Electronic] United States
PMID22096485 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mannose-Binding Lectin
  • Recombinant Proteins
  • Hepatocyte Growth Factor
  • Plasminogen
  • Metalloendopeptidases
  • meprin A
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Blotting, Northern
  • Cell Line
  • Cell Movement (drug effects, genetics)
  • Colorectal Neoplasms (complications, genetics, metabolism)
  • Dogs
  • Female
  • Hepatocyte Growth Factor (pharmacology)
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Immunoprecipitation
  • In Vitro Techniques
  • Liver Neoplasms (genetics, metabolism, secondary)
  • Male
  • Mannose-Binding Lectin (genetics, metabolism)
  • Metalloendopeptidases (genetics, metabolism, pharmacology)
  • Middle Aged
  • Neovascularization, Physiologic (drug effects)
  • Plasminogen (pharmacology)
  • Rats
  • Recombinant Proteins (genetics, metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: